Cuspis Capital III Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net income was CAD 0.040696 million compared to net loss of CAD 0.758192 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.49 CAD | +6.52% | +2.08% | -30.46% |
May. 27 | Cytophage Technologies Ltd. Strengthens Board of Directors | CI |
Apr. 30 | Cuspis Capital III Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-30.46% | 15.37M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- CYTO Stock
- News Cytophage Technologies Ltd.
- Cuspis Capital III Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023